Oregon launches legal psilocybin access to the public

Scientists developed new compounds derived from psilocybin, the active ingredient in “magic mushrooms”, that are designed to reduce the psychedelic effects associated with psilocybin while maintaining its therapeutic benefits.

Amanita Muscaria vs. Psychedelic Mushrooms (Psilocybin): What's the Difference?

Single-Dose Psilocybin for Major Depressive Disorder: Randomized Clinical Trial

Psychedelic psilocybin-assisted therapy reduces depressive symptoms in adults with cancer and depression

Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder was safe and feasible

Psilocybin analog leads to 79% of remission in mid-stage depression trial

Exploring the Impact of Psilocybin on the Immune System: Insights from a Controlled Study on Healthy Participants

Psilocybin-Assisted Therapy for Depression: A review and meta-Analysis finds psilocybin to have a significantly greater antidepressant effect compared to the placebo drug used

Psilocybin might be effective for treatment-resistant depression even with ongoing SSRI use, study suggests